Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-011991

President, R&D sold 22,994 shares at an average $20.94 ($481,577)

  • President, R&D acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-02-22 Option exercise +8,000 $4.12 $32,960 117,920 D: show line 1 in the form
Bergstrom Donald A President, R&D 2022-02-22 Sale −8,000 $20.94 $167,520 109,920 D: show line 2 in the form
Bergstrom Donald A President, R&D 2022-02-22 Sale −12,242 $20.94 $256,347 97,678 D: show line 3 in the form
Bergstrom Donald A President, R&D 2022-02-22 Sale −2,752 $20.97 $57,709 94,926 D: show line 4 in the form
Open-market sales · 22,994 sh · avg $20.94 · $481,577

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2022-02-22 Option exercise · Stock Option (Right to Buy) −8,000 245,456 D: show line 5 in the form
Loading xslF345X03/doc4.xml…